A genome-scale CRISPR-Cas9 screening method for protein stability reveals novel regulators of Cdc25A

被引:27
|
作者
Wu, Yuanzhong [1 ]
Zhou, Liwen [1 ]
Wang, Xin [1 ]
Lu, Jinping [2 ,3 ]
Zhang, Ruhua [1 ]
Liang, Xiaoting [1 ]
Wang, Li [1 ]
Deng, Wuguo [1 ]
Zeng, Yi-Xin [1 ]
Huang, Haojie [1 ,4 ]
Kang, Tiebang [1 ,5 ]
机构
[1] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China
[2] Jinan Univ, Zhuhai Hosp, Zhuhai Peoples Hosp, Clin Lab, Zhuhai, Peoples R China
[3] Jinan Univ, Med Res Ctr, Zhuhai, Peoples R China
[4] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN USA
[5] Guangzhou Doublle Bioprod Co Ltd, Guangdong Prov Key Lab Tumor Targeted Drugs, Guangzhou, Guangdong, Peoples R China
关键词
acetylation; Cdc25A; CRISPR-Cas9; screening; protein stability; ubiquitination; SCF UBIQUITIN LIGASE; BETA-TRCP; DEGRADATION; CELLS; NETWORKS; INSIGHTS;
D O I
10.1038/celldisc.2016.14
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The regulation of stability is particularly crucial for unstable proteins in cells. However, a convenient and unbiased method of identifying regulators of protein stability remains to be developed. Recently, a genome-scale CRISPR-Cas9 library has been established as a genetic tool to mediate loss-of-function screening. Here, we developed a protein stability regulators screening assay (Pro-SRSA) by combining the whole-genome CRISPR-Cas9 library with a dual-fluorescence-based protein stability reporter and high-throughput sequencing to screen for regulators of protein stability. Using Cdc25A as an example, Cul4B-DDB1DCAF8 was identified as a new E3 ligase for Cdc25A. Moreover, the acetylation of Cdc25A at lysine 150, which was acetylated by p300/CBP and deacetylated by HDAC3, prevented the ubiquitin-mediated degradation of Cdc25A by the proteasome. This is the first study to report that acetylation, as a novel posttranslational modification, modulates Cdc25A stability, and we suggest that this unbiased CRISPR-Cas9 screening method at the genome scale may be widely used to globally identify regulators of protein stability.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Genome-Scale CRISPR/Cas9 Screening Reveals Squalene Epoxidase as a Susceptibility Factor for Cytotoxicity of Malformin A1
    Koizumi, Yukio
    Fukushima, Jun
    Kobayashi, Yayoi
    Kadowaki, Ayumi
    Natsui, Miyuki
    Yamaguchi, Tomokazu
    Imai, Yumiko
    Sugiyama, Toshihiro
    Kuba, Keiji
    CHEMBIOCHEM, 2019, 20 (12) : 1563 - 1568
  • [42] A genome-scale CRISPR/Cas9 knockout screening reveals SH3D21 as a sensitizer for gemcitabine
    Mohammad Masoudi
    Motoaki Seki
    Razieh Yazdanparast
    Nozomu Yachie
    Hiroyuki Aburatani
    Scientific Reports, 9
  • [43] CRISPR-Cas9 genome editing in iPSCs for functional genetic screening
    Isachenko, Nadja
    Hu, Dongfang
    Chenchik, Alex
    Diehl, Paul
    Tedesco, Donato
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [45] Genome-wide CRISPR-Cas9 screening in mammalian cells
    Yu, Jason S. L.
    Yusa, Kosuke
    METHODS, 2019, 164 : 29 - 35
  • [46] CRISPR-Cas9 genome editing in iPSCs for functional genetic screening
    Isachenko, N.
    Hu, D.
    Chenchik, A.
    Diehl, P.
    Tedesco, D.
    MOLECULAR BIOLOGY OF THE CELL, 2023, 34 (02) : 859 - 859
  • [47] CRISPR-Cas9 screening reveals novel targets that govern HNSCC response to radiation therapy
    Kelley, Vanessa M.
    Baro, Marta
    Katoch, Aanchal
    Phoomak, Chatchai
    Lee, Hojin
    Contessa, Joseph
    CANCER RESEARCH, 2022, 82 (12)
  • [48] Genome-scale CRISPR-Cas9 screen of Wnt/β-catenin signaling identifies therapeutic targets for colorectal cancer
    Wan, Chunhua
    Mahara, Sylvia
    Sun, Claire
    Doan, Anh
    Chua, Hui Kheng
    Xu, Dakang
    Bian, Jia
    Li, Yue
    Zhu, Danxi
    Sooraj, Dhanya
    Cierpicki, Tomasz
    Grembecka, Jolanta
    Firestein, Ron
    SCIENCE ADVANCES, 2021, 7 (21):
  • [49] Combined genome-scale CRISPR-Cas9 knockout screening with transcriptome sequencing to identify paclitaxel related drivers in triple negative breast cancer
    Lian, Bi
    Xin, Hu
    Shao Zhimin
    CANCER RESEARCH, 2018, 78 (04)
  • [50] Identification of Novel Transcriptional Regulators of Uncoupling Protein 1 Using a Modified CRISPR-Cas9 Methodology
    Darcy, Justin
    Wang, Chih-Hao
    Lundh, Morten
    Shamsi, Farnaz
    Lynes, Matt
    Emanuelli, Brice
    Tseng, Yu-Hua
    DIABETES, 2018, 67